Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT00433836
- Locations
- 🇮🇹
Sites in Italy, Sites in Italy, Italy
🇫🇷Sites in France, Sites in France, France
🇸🇪Sites in Sweden, Sites in Sweden, Sweden
Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.
- First Posted Date
- 2007-02-08
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00432627
- Locations
- 🇩🇪
Novartis Investigative Site, Kiel, Germany
Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 48
- Registration Number
- NCT00432068
- Locations
- 🇮🇹
Novartis Investigative Site, Verona, Italy
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
- Conditions
- Skin Diseases, InfectiousSoft Tissue Infections
- Interventions
- First Posted Date
- 2007-02-02
- Last Posted Date
- 2012-07-16
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 194
- Registration Number
- NCT00430937
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
- Conditions
- Chronic Myeloid Leukemia (CML)
- Interventions
- Drug: Imatinib/Acetaminophen
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 12
- Registration Number
- NCT00428909
- Locations
- 🇰🇷
Novartis Investigative Site, Seoul, Korea, Republic of
Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
- Conditions
- Malignant Peripheral Nerve Sheath Tumors
- Interventions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 11
- Registration Number
- NCT00427583
- Locations
- 🇩🇪
Novartis Investigative Site, Hamburg, Germany
Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 67
- Registration Number
- NCT00427999
- Locations
- 🇩🇪
Novartis Investigative Site, Tübingen, Germany
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors
- First Posted Date
- 2007-01-25
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 48
- Registration Number
- NCT00426582
- Locations
- 🇺🇸
Wertz Clinical Cancer Center (Wayne State University), Detroit, Michigan, United States
🇺🇸Cancer Research and Treatment Center (University of New Mexico), Albuquerque, New Mexico, United States
🇺🇸Norwalk Hospital, Norwalk, Connecticut, United States
Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- First Posted Date
- 2007-01-24
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 50
- Registration Number
- NCT00426530
- Locations
- 🇸🇪
Novartis Investigative Site, Stockholm, Sweden
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2007-01-24
- Last Posted Date
- 2015-12-28
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 88
- Registration Number
- NCT00426556
- Locations
- 🇺🇸
Compassionate Cancer Care Medical Group Dept.ofCCCMG, Fountain Valley, California, United States
🇺🇸University of California at Los Angeles Dept.of UCLA Dept.ofMed., Los Angeles, California, United States
🇺🇸Cancer Centers of the Carolinas CC of C -Eastside, Greenville, South Carolina, United States